These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Synthesis, stability studies, anti-inflammatory activity and ulcerogenicity of morpholinoalkyl ester prodrugs of niflumic acid. Talath S; Gadad AK Arzneimittelforschung; 2006; 56(11):744-52. PubMed ID: 17220052 [TBL] [Abstract][Full Text] [Related]
4. [The beta-morpholino ethyl ester of niflumic acid in the treatment of orchi-epididymitis]. Mazeman E; Biserte J Lille Med; 1980 Nov; 25(9):541-4. PubMed ID: 7453494 [No Abstract] [Full Text] [Related]
5. [Controlled clinical study on the use of morniflumate in the treatment of inflammatory-degenerative diseases of the locomotor system]. Raffaetà G; Saponati G; Terzuoli A G Clin Med; 1987 Oct; 68(10):507-13. PubMed ID: 3428515 [No Abstract] [Full Text] [Related]
6. Short-term tolerability of morniflumate in patients with cutaneous hypersensitivity reactions to non-steroidal anti-inflammatory drugs. Mero F; Nettis E; Aloia AM; Di Leo E; Ferrannini A; Vacca A Int J Immunopathol Pharmacol; 2013; 26(1):247-50. PubMed ID: 23527729 [TBL] [Abstract][Full Text] [Related]
7. [Beta-morpholinoethyl ester of niflumic acid following surgery for vesico-ureteral reflux in children]. Mazeman E; Biserte J; Willot I LARC Med; 1982 Nov; 2(10):915-6. PubMed ID: 7167000 [No Abstract] [Full Text] [Related]
8. Efficacy and safety of morniflumate for the treatment of symptoms associated with soft tissue inflammation. Cremonesi G; Cavalieri L J Int Med Res; 2015 Jun; 43(3):290-302. PubMed ID: 25921871 [TBL] [Abstract][Full Text] [Related]
9. The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity. Nakamura H; Yokoyama Y; Motoyoshi S; Ishii K; Imazu C; Seto Y; Kadokawa T; Shimizu M Arzneimittelforschung; 1983; 33(11):1555-69. PubMed ID: 6607053 [TBL] [Abstract][Full Text] [Related]
11. [Therapeutic effects of niflumic acid, new non-steroidal anti-inflammatory analgesic, by means of double blind test in the field of oral surgery. (II). Its effects on the post operative inflammation in oral surgery (author's transl)]. Michi K; Tozuka M; Iwaki H; Nagumo M; Kurachi Y Nihon Koku Geka Gakkai Zasshi; 1976; 22(2):244-51. PubMed ID: 1075317 [No Abstract] [Full Text] [Related]
12. Simultaneous determination of morniflumate and its major active metabolite, niflumic acid, in human plasma by high-performance liquid chromatography in stability and pharmacokinetic studies. Cho HY; Park GK; Lee YB Biomed Chromatogr; 2013 Nov; 27(11):1438-43. PubMed ID: 23722315 [TBL] [Abstract][Full Text] [Related]
13. Pharmacology of the potent new non-steroidal anti-inflammatory agent aceclofenac. Grau M; Guasch J; Montero JL; Felipe A; Carrasco E; Juliá S Arzneimittelforschung; 1991 Dec; 41(12):1265-76. PubMed ID: 1815528 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of new heteroaryl carboxylic acid derivatives as anti-inflammatory-analgesic agents. Abouzid KA; Khalil NA; Ahmed EM; Zaitone SA Chem Pharm Bull (Tokyo); 2013; 61(2):222-8. PubMed ID: 23370197 [TBL] [Abstract][Full Text] [Related]
15. [Pharmacological studies on niflumic acid, with special reference to the comparison with fenametes. 1. Anti-inflammatory and analgesic actions]. Tsurumi K; Nozaki M; Hayashi M; Yamaguchi A; Hiramatsu Y Nihon Yakurigaku Zasshi; 1972 Nov; 68(6):668-82. PubMed ID: 4676611 [No Abstract] [Full Text] [Related]
16. Modeling population pharmacokinetics of morniflumate in healthy Korean men: extending pharmacometrics analysis to niflumic acid, its major active metabolite. Jeong SH; Jang JH; Lee YB Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; 397(2):843-856. PubMed ID: 37515737 [TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory, analgesic and anti-pyretic effects of d-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid (M-5011), a new non-steroidal anti-inflammatory drug, in rats and guinea pigs. Kido H; Murakami N; Ito A; Kimura K; Kodera N; Doi T; Naruse T Jpn J Pharmacol; 1998 Jan; 76(1):75-86. PubMed ID: 9517407 [TBL] [Abstract][Full Text] [Related]
18. [A new anti-inflammatory-analgesic-antipyretic, morniflumate, in the treatment of chronic recurring bronchitis]. Melica A; Donateo L; Gerardi R; Parenti M Riv Eur Sci Med Farmacol; 1991; 13(1-2):51-60. PubMed ID: 1796197 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological studies of a new non-steroidal antiinflammatory drug: 2-(5-ethylpyridin-2-yl)benzimidazole (KB-1043). Ito K; Kagaya H; Fukuda T; Yoshino K; Nose T Arzneimittelforschung; 1982; 32(1):49-55. PubMed ID: 6977364 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and Biological Evaluation of Mutual Prodrugs of Carboxylic Group Containing Some Non-Steroidal Anti-Inflammatory Drugs and Propyphenazone. Paliwal M; Sucheta ; Ruchita ; Jain S; Monika ; Himanshu Curr Drug Deliv; 2017; 14(8):1213-1224. PubMed ID: 28201966 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]